Why Is There An Increasing Need For Pharmaceutical RND? Aging Population
Why Is There An Increasing Need For Pharmaceutical RND? Aging Population
Why Is There An Increasing Need For Pharmaceutical RND? Aging Population
1) Manufacturing units
3) Marketing units
The pharmaceutical industry has made a great deal of progress over the last decade due to a
research-oriented approach that has improved technologies, developed infrastructures, and
increased research in the field of bioscience.
Aging population
Worldwide, the average human life span has increased substantially over the last few decades.
However, more infections and diseases have come along with this longevity growth. This has led to
increased research on aging populations. The goals are to prevent infections and maintain health so
that these populations can enjoy better lives.
Changing lifestyles
Hectic daily schedules have led to unhealthy eating habits, a lack of exercise, less sleep, and other
problematic lifestyle choices. This has resulted in high obesity rates, poor digestion, hallucinations,
breathing difficulties, and other physical problems. Health supplements have been introduced to
remedy all of these issues, reduce the chance of getting sick, and meet daily nutritional needs
through vitamins and minerals.
The middle class has been growing in both the emerging and developed markets. People in these
markets have more disposable income and expect better healthcare solutions.Chronic disease cases
have risen in number. This has made people become more dependent on medications and health
supplements.
Other economic trends
Globalization and urbanization have led to increased environmental disturbances. These are major
driving forces in the growing demand for improved medication and health supplements for each age
group and geographic location.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large
pool of scientists and engineers who have the potential to steer the industry ahead to an even
higher level.
Road Ahead
Medicine spending in India is projected to grow 9-12 per cent over the next five years, leading India
to become one of the top 10 countries in terms of medicine spending.
Going forward, better growth in domestic sales would also depend on the ability of companies to
align their product portfolio towards chronic therapies for diseases such as such as cardiovascular,
anti-diabetes, anti-depressants and anti-cancers that are on the rise.
The Indian government has taken many steps to reduce costs and bring down healthcare expenses.
Speedy introduction of generic drugs into the market has remained in focus and is expected to
benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes,
lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.